Role of Chk1 gene in molecular classification and prognosis of gastric cancer using immunohistochemistry and LORD-Q assay

Future Oncol. 2022 Aug;18(25):2827-2841. doi: 10.2217/fon-2021-1546. Epub 2022 Jun 28.

Abstract

Purpose: The aim of the current study was to assess the prognostic value of the Chk1 gene in the DNA damage response pathway in gastric cancer (GC). Methods: Expression levels of the Chk1 were measured in 220 GC tumor tissues and adjacent healthy/noncancerous tissues using real-time PCR and immunohistochemical staining. Genomic instability in GC patients was measured using the long-run real-time PCR technique for DNA-damage quantification assay and comet assay. Results: Significantly downregulated expression of Chk1 was observed at the mRNA level (p < 0.0001) and protein level (p < 0.0001). Significantly increased frequency of lesions/10 kb and comets was observed in tumor tissues compared with control tissues. Conclusion: The data suggest that downregulated expression of Chk1 and positive Heliobacter pylori infection status may have prognostic significance in GC.

Keywords: Chk1; DDR pathway; Helicobacter pylori; gastric cancer.

MeSH terms

  • Helicobacter Infections* / genetics
  • Helicobacter pylori* / genetics
  • Humans
  • Immunohistochemistry
  • Prognosis
  • Real-Time Polymerase Chain Reaction
  • Stomach Neoplasms* / diagnosis
  • Stomach Neoplasms* / genetics
  • Stomach Neoplasms* / metabolism